ACAD
NASDAQ HealthcareACADIA Pharmaceuticals Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $21.27 |
|---|---|
| Volume | 1,314,077 |
| Market Cap | 3.63B |
| Beta | 0.810 |
| RSI (14-Day) | 32.1 |
| 200-Day MA | $23.79 |
| 50-Day MA | $24.74 |
| 52-Week High | $28.35 |
| 52-Week Low | $13.40 |
| P/E Ratio | 9.25 |
| Forward P/E | 23.51 |
| Price / Book | 2.95 |
🎯 Investment Strategy Scores
How ACAD scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
38/100
High dividend yield + low volatility
🚀 Moon Shot
48/100
High growth potential (high beta + oversold)
🔪 Falling Knife
70/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
36/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
53/100
Large-cap, institutional-quality stocks
Find ACAD in your text
Paste any text on the homepage — the tool will extract ACAD and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.